AxoGen, Inc. (0HKD.L)
USD 15.99
(3.09%)
USD 15.99
(3.09%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 159.01 Million USD | 14.74% |
| 2022 | 138.58 Million USD | 8.81% |
| 2021 | 127.35 Million USD | 13.41% |
| 2020 | 112.3 Million USD | 5.24% |
| 2019 | 106.71 Million USD | 27.13% |
| 2018 | 83.93 Million USD | 38.91% |
| 2017 | 60.42 Million USD | 47.0% |
| 2016 | 41.1 Million USD | 50.41% |
| 2015 | 27.33 Million USD | 62.52% |
| 2014 | 16.81 Million USD | 53.62% |
| 2013 | 10.94 Million USD | 42.33% |
| 2012 | 7.69 Million USD | 58.61% |
| 2011 | 4.84 Million USD | 5213.15% |
| 2010 | 91.27 Thousand USD | -99.63% |
| 2009 | 24.91 Million USD | 34160.81% |
| 2008 | 72.71 Thousand USD | -27.6% |
| 2007 | 100.43 Thousand USD | -20.71% |
| 2006 | 126.66 Thousand USD | -71.43% |
| 2005 | 443.35 Thousand USD | -58.37% |
| 2004 | 1.06 Million USD | -85.28% |
| 2003 | 7.23 Million USD | 5.62% |
| 2002 | 6.85 Million USD | -56.98% |
| 2001 | 15.92 Million USD | 9.13% |
| 2000 | 14.59 Million USD | 18.67% |
| 1999 | 12.3 Million USD | -4.65% |
| 1998 | 12.9 Million USD | 4.88% |
| 1997 | 12.3 Million USD | -6.11% |
| 1996 | 13.1 Million USD | -7.09% |
| 1995 | 14.1 Million USD | 31.78% |
| 1994 | 10.7 Million USD | 16.3% |
| 1993 | 9.2 Million USD | 13.58% |
| 1992 | 8.1 Million USD | 1.25% |
| 1991 | 8 Million USD | 17.65% |
| 1990 | 6.8 Million USD | 6.25% |
| 1989 | 6.4 Million USD | 10.34% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 41.37 Million USD | -3.6% |
| 2024 Q2 | 47.91 Million USD | 15.79% |
| 2023 Q4 | 42.92 Million USD | 4.0% |
| 2023 Q2 | 38.15 Million USD | 4.07% |
| 2023 Q3 | 41.27 Million USD | 8.17% |
| 2023 Q1 | 36.66 Million USD | 1.38% |
| 2023 FY | 159.01 Million USD | 14.74% |
| 2022 Q2 | 34.45 Million USD | 11.12% |
| 2022 Q3 | 36.95 Million USD | 7.27% |
| 2022 Q4 | 36.16 Million USD | -2.15% |
| 2022 Q1 | 31 Million USD | -1.68% |
| 2022 FY | 138.58 Million USD | 8.81% |
| 2021 Q3 | 31.2 Million USD | -7.08% |
| 2021 Q1 | 31.03 Million USD | -4.49% |
| 2021 FY | 127.35 Million USD | 13.41% |
| 2021 Q4 | 31.53 Million USD | 1.07% |
| 2021 Q2 | 33.58 Million USD | 8.19% |
| 2020 Q1 | 24.26 Million USD | -13.85% |
| 2020 FY | 112.3 Million USD | 5.24% |
| 2020 Q4 | 32.49 Million USD | -2.79% |
| 2020 Q3 | 33.42 Million USD | 51.15% |
| 2020 Q2 | 22.11 Million USD | -8.84% |
| 2019 Q1 | 23.28 Million USD | -0.63% |
| 2019 FY | 106.71 Million USD | 27.13% |
| 2019 Q3 | 28.56 Million USD | 6.98% |
| 2019 Q4 | 28.16 Million USD | -1.41% |
| 2019 Q2 | 26.7 Million USD | 14.67% |
| 2018 Q3 | 22.66 Million USD | 10.08% |
| 2018 Q4 | 23.43 Million USD | 3.41% |
| 2018 FY | 83.93 Million USD | 38.91% |
| 2018 Q2 | 20.58 Million USD | 19.26% |
| 2018 Q1 | 17.25 Million USD | 1.7% |
| 2017 Q1 | 12.24 Million USD | 7.3% |
| 2017 Q2 | 15.16 Million USD | 23.91% |
| 2017 Q3 | 16.04 Million USD | 5.79% |
| 2017 FY | 60.42 Million USD | 47.0% |
| 2017 Q4 | 16.97 Million USD | 5.76% |
| 2016 Q2 | 10.38 Million USD | 27.99% |
| 2016 Q1 | 8.11 Million USD | 3.88% |
| 2016 FY | 41.1 Million USD | 50.41% |
| 2016 Q3 | 11.2 Million USD | 7.93% |
| 2016 Q4 | 11.4 Million USD | 1.82% |
| 2015 FY | 27.33 Million USD | 62.52% |
| 2015 Q4 | 7.8 Million USD | -4.23% |
| 2015 Q1 | 4.95 Million USD | 3.29% |
| 2015 Q2 | 6.41 Million USD | 29.61% |
| 2015 Q3 | 8.15 Million USD | 27.06% |
| 2014 Q1 | 3.13 Million USD | 5.15% |
| 2014 FY | 16.81 Million USD | 53.62% |
| 2014 Q4 | 4.79 Million USD | 2.62% |
| 2014 Q3 | 4.67 Million USD | 10.85% |
| 2014 Q2 | 4.21 Million USD | 34.28% |
| 2013 Q4 | 2.98 Million USD | 0.92% |
| 2013 Q2 | 2.86 Million USD | 33.57% |
| 2013 Q1 | 2.14 Million USD | 4.79% |
| 2013 FY | 10.94 Million USD | 42.33% |
| 2013 Q3 | 2.95 Million USD | 3.33% |
| 2012 Q4 | 2.04 Million USD | 3.23% |
| 2012 FY | 7.69 Million USD | 58.61% |
| 2012 Q3 | 1.98 Million USD | -1.57% |
| 2012 Q2 | 2.01 Million USD | 21.72% |
| 2012 Q1 | 1.65 Million USD | 21.43% |
| 2011 Q1 | 3.62 Million USD | 8506.99% |
| 2011 Q2 | 2.24 Million USD | -38.09% |
| 2011 Q3 | 1.14 Million USD | -49.17% |
| 2011 FY | 4.84 Million USD | 5213.15% |
| 2011 Q4 | 1.36 Million USD | 19.36% |
| 2010 Q3 | 26.37 Thousand USD | 710.48% |
| 2010 Q4 | 42.11 Thousand USD | 59.7% |
| 2010 FY | 91.27 Thousand USD | -99.63% |
| 2010 Q1 | 19.52 Thousand USD | -99.92% |
| 2010 Q2 | 3254.00 USD | -83.34% |
| 2009 Q4 | 24.23 Million USD | 99981.53% |
| 2009 FY | 24.91 Million USD | 34160.81% |
| 2009 Q3 | 24.21 Thousand USD | -96.03% |
| 2009 Q1 | 42.1 Thousand USD | 29.22% |
| 2009 Q2 | 610.31 Thousand USD | 1349.43% |
| 2008 FY | 72.71 Thousand USD | -27.6% |
| 2008 Q1 | 21.02 Thousand USD | 0.0% |
| 2008 Q4 | 32.58 Thousand USD | 132.39% |
| 2008 Q3 | 14.02 Thousand USD | 176.3% |
| 2008 Q2 | 5075.00 USD | -75.87% |
| 2007 FY | 100.43 Thousand USD | -20.71% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 Q3 | 34.38 Thousand USD | 0.0% |
| 2006 Q2 | - USD | -100.0% |
| 2006 Q1 | 92.27 Thousand USD | -63.69% |
| 2006 FY | 126.66 Thousand USD | -71.43% |
| 2006 Q4 | - USD | -100.0% |
| 2005 FY | 443.35 Thousand USD | -58.37% |
| 2005 Q3 | 68.71 Thousand USD | 75.38% |
| 2005 Q2 | 39.18 Thousand USD | -51.8% |
| 2005 Q1 | 81.29 Thousand USD | 0.0% |
| 2005 Q4 | 254.15 Thousand USD | 269.86% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | 2.47 Million USD | 24.66% |
| 2004 Q2 | 1.52 Million USD | -38.69% |
| 2004 FY | 1.06 Million USD | -85.28% |
| 2004 Q3 | - USD | -100.0% |
| 2003 Q1 | 1.64 Million USD | -5.45% |
| 2003 Q2 | 1.62 Million USD | -1.29% |
| 2003 Q4 | 1.98 Million USD | 0.55% |
| 2003 FY | 7.23 Million USD | 5.62% |
| 2003 Q3 | 1.97 Million USD | 21.77% |
| 2002 Q1 | 1.51 Million USD | 0.0% |
| 2002 Q4 | 1.74 Million USD | -13.57% |
| 2002 Q3 | 2.01 Million USD | 27.22% |
| 2002 Q2 | 1.58 Million USD | 4.52% |
| 2002 FY | 6.85 Million USD | -56.98% |
| 2001 FY | 15.92 Million USD | 9.13% |
| 2001 Q3 | 2.72 Million USD | -22.4% |
| 2001 Q2 | 3.51 Million USD | -15.82% |
| 2001 Q1 | 4.17 Million USD | 2.84% |
| 2000 Q2 | 4.35 Million USD | 10.63% |
| 2000 FY | 14.59 Million USD | 18.67% |
| 2000 Q1 | 3.93 Million USD | 19.24% |
| 2000 Q3 | 4.18 Million USD | -3.77% |
| 2000 Q4 | 4.05 Million USD | -3.16% |
| 1999 Q1 | 3.2 Million USD | 3.23% |
| 1999 FY | 12.3 Million USD | -4.65% |
| 1999 Q4 | 3.3 Million USD | 10.0% |
| 1999 Q3 | 3 Million USD | -3.23% |
| 1999 Q2 | 3.1 Million USD | -3.13% |
| 1998 Q1 | 3.3 Million USD | 0.0% |
| 1998 Q3 | 2.9 Million USD | 7.41% |
| 1998 Q4 | 3.1 Million USD | 6.9% |
| 1998 FY | 12.9 Million USD | 4.88% |
| 1998 Q2 | 2.7 Million USD | -18.18% |
| 1997 Q2 | 3.3 Million USD | 10.0% |
| 1997 Q4 | 3.3 Million USD | -8.33% |
| 1997 FY | 12.3 Million USD | -6.11% |
| 1997 Q1 | 3 Million USD | 0.0% |
| 1997 Q3 | 3.6 Million USD | 9.09% |
| 1996 Q4 | 3 Million USD | 0.0% |
| 1996 Q2 | 2.6 Million USD | -31.58% |
| 1996 FY | 13.1 Million USD | -7.09% |
| 1996 Q1 | 3.8 Million USD | 15.15% |
| 1996 Q3 | 3 Million USD | 15.38% |
| 1995 Q2 | 3.3 Million USD | -21.43% |
| 1995 Q4 | 3.3 Million USD | -5.71% |
| 1995 FY | 14.1 Million USD | 31.78% |
| 1995 Q3 | 3.5 Million USD | 6.06% |
| 1995 Q1 | 4.2 Million USD | 13.51% |
| 1994 Q4 | 3.7 Million USD | 27.59% |
| 1994 FY | 10.7 Million USD | 16.3% |
| 1994 Q1 | 2.3 Million USD | -8.0% |
| 1994 Q2 | 2.8 Million USD | 21.74% |
| 1994 Q3 | 2.9 Million USD | 3.57% |
| 1993 Q2 | 2.9 Million USD | 26.09% |
| 1993 Q1 | 2.3 Million USD | 21.05% |
| 1993 FY | 9.2 Million USD | 13.58% |
| 1993 Q4 | 2.5 Million USD | -19.35% |
| 1993 Q3 | 3.1 Million USD | 6.9% |
| 1992 Q1 | 2 Million USD | 5.26% |
| 1992 Q2 | 2.1 Million USD | 5.0% |
| 1992 Q3 | 2.1 Million USD | 0.0% |
| 1992 Q4 | 1.9 Million USD | -9.52% |
| 1992 FY | 8.1 Million USD | 1.25% |
| 1991 Q1 | 2.1 Million USD | 5.0% |
| 1991 Q4 | 1.9 Million USD | -9.52% |
| 1991 Q3 | 2.1 Million USD | -4.55% |
| 1991 FY | 8 Million USD | 17.65% |
| 1991 Q2 | 2.2 Million USD | 4.76% |
| 1990 FY | 6.8 Million USD | 6.25% |
| 1990 Q3 | 1.7 Million USD | 112.98% |
| 1990 Q4 | 2 Million USD | 17.65% |
| 1990 Q1 | 10.4 Million USD | 38.67% |
| 1990 Q2 | -13.1 Million USD | -225.96% |
| 1989 Q1 | 1.6 Million USD | -5.88% |
| 1989 Q4 | 7.5 Million USD | 294.74% |
| 1989 FY | 6.4 Million USD | 10.34% |
| 1989 Q3 | 1.9 Million USD | 18.75% |
| 1989 Q2 | 1.6 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | 55.371% |
| Accuray Incorporated | 446.55 Million USD | 64.391% |
| Align Technology, Inc. | 3.86 Billion USD | 95.883% |
| Elevance Health Inc. | 171.34 Billion USD | 99.907% |
| Boston Scientific Corporation | 14.24 Billion USD | 98.883% |
| CVS Health Corporation | 357.77 Billion USD | 99.956% |
| Cardinal Health, Inc. | 226.82 Billion USD | 99.93% |
| Centene Corporation | 141.26 Billion USD | 99.887% |
| DaVita Inc. | 12.14 Billion USD | 98.69% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 99.755% |
| Hologic, Inc. | 4.03 Billion USD | 96.055% |
| Humana Inc. | 106.37 Billion USD | 99.851% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | 95.657% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | 98.693% |
| Masimo Corporation | 2.04 Billion USD | 92.236% |
| McKesson Corporation | 308.95 Billion USD | 99.949% |
| Patterson Companies, Inc. | 6.56 Billion USD | 97.579% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | 98.281% |
| ResMed Inc. | 4.68 Billion USD | 96.606% |
| Henry Schein, Inc. | 12.33 Billion USD | 98.711% |
| Teladoc Health, Inc. | 2.6 Billion USD | 93.89% |
| Universal Health Services, Inc. | 14.28 Billion USD | 98.887% |
| Veeva Systems Inc. | 2.36 Billion USD | 93.273% |
| Baxter International Inc. | 14.81 Billion USD | 98.927% |
| Becton, Dickinson and Company | 19.37 Billion USD | 99.179% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 97.768% |
| Danaher Corporation | 23.89 Billion USD | 99.334% |
| Stryker Corporation | 20.49 Billion USD | 99.224% |
| Medtronic plc | 32.36 Billion USD | 99.509% |